CMS Delays New Medicaid Rebate Rules For 5i Drugs, But Rest Of Rule In Effect

The Medicaid drug rebate regulation took effect April 1 -- despite calls by pharmacies, drug makers and drug distributors to delay it -- but on March 31 CMS announced a “transition period” for so-called 5i drugs, which account for a portion of the drugs under the rule, due to data system issues. Drug makers had told CMS that the April 1, 2016, effective date didn't give them enough lead time to incorporate the changes in the final rule into their...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.